GSN and breast carcinoma: Scumaci et al. demonstrated reduced gelsolin in plasma samples of patients with hereditary breast cancer and correlated this observation with BRCA1 mutation status, suggesting that gelsolin expression is modulated by BRCA1-dependent recruiting of ATF-1 (i.e., factor binding to GSN promoter and negatively controlling its activity).